Device Center Moves To Better Prioritize Its Scientific Work-thegraysheet: FDA’s device center has created a Regulatory Science Subcommittee to identify and prioritize scientific needs, and the Office of Science and Engineering Laboratories is considering restructuring to enhance its responsiveness to regulatory science issues. These are just two changes afoot at CDRH in response to recommendations in a report written by the FDA Science Board’s CDRH Research Review Subcommittee and approved by the full Science Board last June.
